CompaniesPelican Therapeutics

Pelican Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

22

By Phase

PHASE1: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
Today
NCT04430348
Hover over trial bars to see details

Recent Trials

NCT04430348Lead Sponsor
PTX-35 in Patients With Advanced Solid Tumors
PHASE1Terminated
22 participants
Started: Jun 4, 2020 · Completed: Jun 15, 2023
Funding History (2)
D
Aug 18, 2015
Filing
D
Jun 9, 2014
Filing